Brigatinib’s a treatment for lung cancer that’s spread and ALK-positive. It’s part of the ALK inhibitor group, stopping that ALK pathway thing. The drug comes in three doses: 30, 90, and 180 milligrams, all as those little film-coated pills.
You should start with 90 mg a day for the first week, then switch to 180 mg every day after that. It comes in bottles with 30 tablets in each one.
